Literature DB >> 16706962

Toward gene therapy for hemophilia A with novel adenoviral vectors: successes and limitations in canine models.

V R Arruda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16706962     DOI： 10.1111/j.1538-7836.2006.01964.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  12 in total

Review 1.  Recent advances in lentiviral vector development and applications.

Authors:  Janka Mátrai; Marinee K L Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2010-01-19       Impact factor: 11.454

Review 2.  Strategies to modulate immune responses: a new frontier for gene therapy.

Authors:  Valder R Arruda; Patricia Favaro; Jonathan D Finn
Journal:  Mol Ther       Date:  2009-07-07       Impact factor: 11.454

Review 3.  Animal models of hemophilia and related bleeding disorders.

Authors:  Jay N Lozier; Timothy C Nichols
Journal:  Semin Hematol       Date:  2013-04       Impact factor: 3.851

4.  Gene therapy: the promise of a permanent cure.

Authors:  Christopher D Porada; Christopher Stem; Graca Almeida-Porada
Journal:  N C Med J       Date:  2013 Nov-Dec

5.  Phenotypic correction of hemophilia A in sheep by postnatal intraperitoneal transplantation of FVIII-expressing MSC.

Authors:  Christopher D Porada; Chad Sanada; Chung-Jung Kuo; Evan Colletti; Walter Mandeville; John Hasenau; Esmail D Zanjani; Robert Moot; Christopher Doering; H Trent Spencer; Graça Almeida-Porada
Journal:  Exp Hematol       Date:  2011-09-08       Impact factor: 3.084

Review 6.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

7.  Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A.

Authors:  C D Porada; C Sanada; C R Long; J A Wood; J Desai; N Frederick; L Millsap; C Bormann; S L Menges; C Hanna; G Flores-Foxworth; T Shin; M E Westhusin; W Liu; H Glimp; E D Zanjani; J N Lozier; V Pliska; G Stranzinger; H Joerg; D C Kraemer; G Almeida-Porada
Journal:  J Thromb Haemost       Date:  2009-11-23       Impact factor: 5.824

8.  Treatment of Hemophilia A in Utero and Postnatally using Sheep as a Model for Cell and Gene Delivery.

Authors:  Christopher D Porada; Graça Almeida-Porada
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-25

9.  Generation of an optimized lentiviral vector encoding a high-expression factor VIII transgene for gene therapy of hemophilia A.

Authors:  J M Johnston; G Denning; C B Doering; H T Spencer
Journal:  Gene Ther       Date:  2012-09-20       Impact factor: 5.250

Review 10.  Hemophilia A: an ideal disease to correct in utero.

Authors:  Christopher D Porada; Christopher Rodman; Glicerio Ignacio; Anthony Atala; Graça Almeida-Porada
Journal:  Front Pharmacol       Date:  2014-12-11       Impact factor: 5.810
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.